As of May 29, 2025, Onconova Therapeutics Inc (ONTX) reports a Graham Number of 6.20.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Onconova Therapeutics Inc's Graham Number
Over recent years, Onconova Therapeutics Inc's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2022-12-31 | 6.20 |
| 2021-12-31 | 6.20 |
This trend highlights how Onconova Therapeutics Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Onconova Therapeutics Inc's Graham Number to Peers
To better understand Onconova Therapeutics Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Onconova Therapeutics Inc (ONTX) | 6.20 |
| Johnson & Johnson (JNJ) | 62.42 |
| Eli Lilly and Co (LLY) | 61.34 |
| Merck & Co Inc (MRK) | 53.07 |
| Catalent Inc (CTLT) | 40.60 |
| Zoetis Inc (ZTS) | 36.62 |
Compared to its competitors, Onconova Therapeutics Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.